Methods for prognosis and monitoring cancer therapy
US8329408B2 · kind B2 · utility
1Cited by
0References
4Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 30, 2006 |
| Grant date | Dec 11, 2012 |
| Priority date | — |
| Expiry date | Oct 30, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/136
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention also relates to biomarkers and the use of biomarkers for the prediction and prognosis of cancer as well as the use of biomarkers to monitor the efficacy of cancer treatment. Specifically, this invention relates to the use of HER-2, EGFR, VEGF, u-PA, p-PAI-1, and soluble forms thereof, as biomarkers for cancer, especially for subjects treated with sorafenib.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.